353 related articles for article (PubMed ID: 30606788)
1. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis.
Mulder FI; Candeloro M; Kamphuisen PW; Di Nisio M; Bossuyt PM; Guman N; Smit K; Büller HR; van Es N;
Haematologica; 2019 Jun; 104(6):1277-1287. PubMed ID: 30606788
[TBL] [Abstract][Full Text] [Related]
2. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis.
van Es N; Ventresca M; Di Nisio M; Zhou Q; Noble S; Crowther M; Briel M; Garcia D; Lyman GH; Macbeth F; Griffiths G; Iorio A; Mbuagbaw L; Neumann I; Brozek J; Guyatt G; Streiff MB; Baldeh T; Florez ID; Gurunlu Alma O; Agnelli G; Ageno W; Marcucci M; Bozas G; Zulian G; Maraveyas A; Lebeau B; Lecumberri R; Sideras K; Loprinzi C; McBane R; Pelzer U; Riess H; Solh Z; Perry J; Kahale LA; Bossuyt PM; Klerk C; Büller HR; Akl EA; Schünemann HJ;
J Thromb Haemost; 2020 Aug; 18(8):1940-1951. PubMed ID: 32336010
[TBL] [Abstract][Full Text] [Related]
3. The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study.
Overvad TF; Skjøth F; Piazza G; Noble S; Ording AG; Larsen TB; Nielsen PB
J Thromb Haemost; 2022 Dec; 20(12):2921-2929. PubMed ID: 36112135
[TBL] [Abstract][Full Text] [Related]
4. [Predicting the Incidence of Venous Thromboembolism Using the Khorana Score: A Literature Review].
Nishimura A; Ikeda Y
Yakugaku Zasshi; 2021; 141(4):611-622. PubMed ID: 33790126
[TBL] [Abstract][Full Text] [Related]
5. Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis.
Bosch FTM; Mulder FI; Kamphuisen PW; Middeldorp S; Bossuyt PM; Büller HR; van Es N
Blood Adv; 2020 Oct; 4(20):5215-5225. PubMed ID: 33104795
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer.
Parker A; Peterson E; Lee AYY; de Wit C; Carrier M; Polley G; Tien J; Wu C
J Thromb Haemost; 2018 Jul; 16(7):1321-1326. PubMed ID: 29733498
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy.
Overvad TF; Ording AG; Nielsen PB; Skjøth F; Albertsen IE; Noble S; Vistisen AK; Gade IL; Severinsen MT; Piazza G; Larsen TB
Blood Adv; 2022 May; 6(10):2967-2976. PubMed ID: 35045569
[TBL] [Abstract][Full Text] [Related]
8. Comparison among three predictive models for cancer-associated thromboembolism in a hispanic population.
Ramos-Esquivel A; Marenco-Flores A; Hernández-Romero G; Céspedes-Calvo A; Mora-Hidalgo R
J Thromb Thrombolysis; 2023 Oct; 56(3):433-438. PubMed ID: 37407771
[TBL] [Abstract][Full Text] [Related]
9. The performance of Khorana risk score for prediction of venous thromboembolism in patients with lung cancer: A retrospective cohort study.
Kizilirmak D; Fidan U; Havlucu Y
Tuberk Toraks; 2024 Jun; 72(2):114-119. PubMed ID: 38869203
[TBL] [Abstract][Full Text] [Related]
10. Ability of the Khorana score to predict recurrent thromboembolism in cancer patients with ischemic stroke.
Murthy SB; Cushman M; Bobrow D; Kamel H; Merkler AE; Elkind MSV; DeAngelis LM; Navi BB
J Clin Neurosci; 2018 Nov; 57():111-115. PubMed ID: 30145085
[TBL] [Abstract][Full Text] [Related]
11. The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer.
van Es N; Franke VF; Middeldorp S; Wilmink JW; Büller HR
Thromb Res; 2017 Feb; 150():30-32. PubMed ID: 28002757
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma.
Sanfilippo KM; Carson KR; Wang TF; Luo S; Edwin N; Kuderer N; Keller JM; Gage BF
Res Pract Thromb Haemost; 2022 Jan; 6(1):e12634. PubMed ID: 35028491
[TBL] [Abstract][Full Text] [Related]
13. A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer.
Li S; Gao P; Qiu J; He X; Mao Y
J Thromb Thrombolysis; 2021 Oct; 52(3):898-903. PubMed ID: 33599857
[TBL] [Abstract][Full Text] [Related]
14. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
Mansfield AS; Tafur AJ; Wang CE; Kourelis TV; Wysokinska EM; Yang P
J Thromb Haemost; 2016 Sep; 14(9):1773-8. PubMed ID: 27273134
[TBL] [Abstract][Full Text] [Related]
15. Provider education program on the Khorana score to promote venous thromboembolism chemoprophylaxis in patients with gynecologic cancer.
Apple A; Prescott L; Robinson M; Shultes K; Brown A
Int J Gynecol Cancer; 2022 Apr; 32(4):547-552. PubMed ID: 35169068
[TBL] [Abstract][Full Text] [Related]
16. Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.
Pelletier R
J Oncol Pharm Pract; 2021 Jun; 27(4):911-918. PubMed ID: 33757321
[TBL] [Abstract][Full Text] [Related]
17. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
[TBL] [Abstract][Full Text] [Related]
18. The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy.
Ramos JD; Casey MF; Bamias A; De Giorgi U; Bellmunt J; Harshman LC; Ladoire S; Wong YN; Alva AS; Rosenberg JE; Galsky MD; Yu EY;
Clin Appl Thromb Hemost; 2017 Oct; 23(7):755-760. PubMed ID: 27637910
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer.
Guman NAM; van Geffen RJ; Mulder FI; van Haaps TF; Hovsepjan V; Labots M; Cirkel GA; Y F L de Vos F; Ten Tije AJ; Beerepoot LV; Tjan-Heijnen VCG; van Laarhoven HWM; Hamberg P; Vulink AJE; Los M; Zwinderman AH; Ferwerda B; Lolkema MPJK; Steeghs N; Büller HR; Kamphuisen PW; van Es N
J Thromb Haemost; 2021 Dec; 19(12):2974-2983. PubMed ID: 34409743
[TBL] [Abstract][Full Text] [Related]
20. Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma.
Vathiotis I; Dimakakos EP; Boura P; Ntineri A; Charpidou A; Gerotziafas G; Syrigos K
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1347-1351. PubMed ID: 29806470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
